Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis

A local antibiotic delivery system (LADS) with biodegradable drug vehicles is recognized as the most effective therapeutic approach for the treatment of osteomyelitis. However, the design of a biodegradable LADS with high therapeutic efficacy is too costly and demanding. In this research, a low-cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Saidykhan, Lamin, Abu Bakar, Md Zuki Bin, Rukayadi, Yaya, Kura, Aminu Umar, Latifah, Saiful Yazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760660/
https://www.ncbi.nlm.nih.gov/pubmed/26929622
http://dx.doi.org/10.2147/IJN.S95885
_version_ 1782416884995457024
author Saidykhan, Lamin
Abu Bakar, Md Zuki Bin
Rukayadi, Yaya
Kura, Aminu Umar
Latifah, Saiful Yazan
author_facet Saidykhan, Lamin
Abu Bakar, Md Zuki Bin
Rukayadi, Yaya
Kura, Aminu Umar
Latifah, Saiful Yazan
author_sort Saidykhan, Lamin
collection PubMed
description A local antibiotic delivery system (LADS) with biodegradable drug vehicles is recognized as the most effective therapeutic approach for the treatment of osteomyelitis. However, the design of a biodegradable LADS with high therapeutic efficacy is too costly and demanding. In this research, a low-cost, facile method was used to design vancomycin-loaded aragonite nanoparticles (VANPs) with the aim of understanding its potency in developing a nanoantibiotic bone implant for the treatment of osteomyelitis. The aragonite nanoparticles (ANPs) were synthesized from cockle shells by a hydrothermal approach using a zwitterionic surfactant. VANPs were prepared using antibiotic ratios of several nanoparticles, and the formulation (1:4) with the highest drug-loading efficiency (54.05%) was used for physicochemical, in vitro drug release, and biological evaluation. Physiochemical characterization of VANP was performed by using transmission electron microscopy, Fourier transform infrared spectroscopy, X-ray powder diffraction, and Zetasizer. No significant differences were observed between VANP and ANP in terms of size and morphology as both samples were cubic shaped with sizes of approximately 35 nm. The Fourier transform infrared spectroscopy of VANP indicated a weak noncovalent interaction between ANP and vancomycin, while the zeta potential values were slightly increased from −19.4±3.3 to −21.2±5.7 mV after vancomycin loading. VANP displayed 120 hours (5 days) release profile of vancomycin that exhibited high antibacterial effect against methicillin-resistant Staphylococcus aureus ATCC 29213. The cell proliferation assay showed 80% cell viability of human fetal osteoblast cell line 1.19 treated with the highest concentration of VANP (250 µg/mL), indicating good biocompatibility of VANP. In summary, VANP is a potential formulation for the development of an LADS against osteomyelitis with optimal antibacterial efficacy, good bone resorbability, and biocompatibility.
format Online
Article
Text
id pubmed-4760660
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47606602016-02-29 Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis Saidykhan, Lamin Abu Bakar, Md Zuki Bin Rukayadi, Yaya Kura, Aminu Umar Latifah, Saiful Yazan Int J Nanomedicine Original Research A local antibiotic delivery system (LADS) with biodegradable drug vehicles is recognized as the most effective therapeutic approach for the treatment of osteomyelitis. However, the design of a biodegradable LADS with high therapeutic efficacy is too costly and demanding. In this research, a low-cost, facile method was used to design vancomycin-loaded aragonite nanoparticles (VANPs) with the aim of understanding its potency in developing a nanoantibiotic bone implant for the treatment of osteomyelitis. The aragonite nanoparticles (ANPs) were synthesized from cockle shells by a hydrothermal approach using a zwitterionic surfactant. VANPs were prepared using antibiotic ratios of several nanoparticles, and the formulation (1:4) with the highest drug-loading efficiency (54.05%) was used for physicochemical, in vitro drug release, and biological evaluation. Physiochemical characterization of VANP was performed by using transmission electron microscopy, Fourier transform infrared spectroscopy, X-ray powder diffraction, and Zetasizer. No significant differences were observed between VANP and ANP in terms of size and morphology as both samples were cubic shaped with sizes of approximately 35 nm. The Fourier transform infrared spectroscopy of VANP indicated a weak noncovalent interaction between ANP and vancomycin, while the zeta potential values were slightly increased from −19.4±3.3 to −21.2±5.7 mV after vancomycin loading. VANP displayed 120 hours (5 days) release profile of vancomycin that exhibited high antibacterial effect against methicillin-resistant Staphylococcus aureus ATCC 29213. The cell proliferation assay showed 80% cell viability of human fetal osteoblast cell line 1.19 treated with the highest concentration of VANP (250 µg/mL), indicating good biocompatibility of VANP. In summary, VANP is a potential formulation for the development of an LADS against osteomyelitis with optimal antibacterial efficacy, good bone resorbability, and biocompatibility. Dove Medical Press 2016-02-15 /pmc/articles/PMC4760660/ /pubmed/26929622 http://dx.doi.org/10.2147/IJN.S95885 Text en © 2016 Saidykhan et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Saidykhan, Lamin
Abu Bakar, Md Zuki Bin
Rukayadi, Yaya
Kura, Aminu Umar
Latifah, Saiful Yazan
Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis
title Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis
title_full Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis
title_fullStr Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis
title_full_unstemmed Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis
title_short Development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis
title_sort development of nanoantibiotic delivery system using cockle shell-derived aragonite nanoparticles for treatment of osteomyelitis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760660/
https://www.ncbi.nlm.nih.gov/pubmed/26929622
http://dx.doi.org/10.2147/IJN.S95885
work_keys_str_mv AT saidykhanlamin developmentofnanoantibioticdeliverysystemusingcockleshellderivedaragonitenanoparticlesfortreatmentofosteomyelitis
AT abubakarmdzukibin developmentofnanoantibioticdeliverysystemusingcockleshellderivedaragonitenanoparticlesfortreatmentofosteomyelitis
AT rukayadiyaya developmentofnanoantibioticdeliverysystemusingcockleshellderivedaragonitenanoparticlesfortreatmentofosteomyelitis
AT kuraaminuumar developmentofnanoantibioticdeliverysystemusingcockleshellderivedaragonitenanoparticlesfortreatmentofosteomyelitis
AT latifahsaifulyazan developmentofnanoantibioticdeliverysystemusingcockleshellderivedaragonitenanoparticlesfortreatmentofosteomyelitis